---
title: "MiMedx Group, Inc. (MDXG.US) — 公司概況"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/MDXG.US/overview.md"
symbol: "MDXG.US"
name: "MiMedx Group, Inc."
parent: "https://longbridge.com/zh-HK/quote/MDXG.US.md"
datetime: "2026-04-17T06:31:36.378Z"
locales:
  - [en](https://longbridge.com/en/quote/MDXG.US/overview.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MDXG.US/overview.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MDXG.US/overview.md)
---

# MiMedx Group, Inc. (MDXG.US) — 公司概況

## 基本資訊

| 項目 | 詳情 |
|------|--------|
| 行業 | 生物技術 |
| 交易所 | US Market |
| 地址 | 1775 West Oak Commons Court, NE, Marietta, Georgia, United States |
| 官網 | [www.mimedx.com](https://www.mimedx.com) |

## 公司簡介

MiMedx Group, Inc. 開發和分銷用于各個醫療領域的胎盤組織同種異體移植物。該公司利用其專利的 PURION 過程處理人類胎盤組織膜、臍帶和胎盤盤，生產保留組織固有生物特性和調節蛋白的同種異體移植物，包括細胞因子、趨化因子和生長因子。其專利的加工方法採用無菌加工技術，並結合終末滅菌

## 核心管理層

| 名稱 | 職位 |
|------|-------|
| Joseph H. Capper | CEO & Director |
| Douglas C. Rice | Chief Financial Officer |
| Ricci S. Whitlow | Executive VP & COO |
| William F. Hulse | General Counsel & Chief Administrative Officer |
| Kimberly Maersk-Moller | Chief Commercial Officer |
| K. Todd Newton | Independent Director |
| James L. Bierman | Independent Director |
| William A. Hawkins | Independent Preferred Director |
| Martin Paul Sutter | Independent Preferred Director |

## 主要股東

| 名稱 | 佔比 | 報告日期 |
|------|-------|-------------|
| Essex Woodlands Management, Inc. | 18.98% | 2025-12-31 |
| BlackRock, Inc. | 7.63% | 2025-12-31 |
| The Vanguard Group, Inc. | 4.84% | 2025-12-31 |
| Trigran Investments, Inc. | 4.15% | 2025-12-31 |
| State Street Global Advisors, Inc. | 2.57% | 2025-12-31 |
| First Light Asset Management, LLC | 2.05% | 2025-12-31 |
| Geode Capital Management, LLC | 1.91% | 2025-12-31 |
| Dimensional Fund Advisors LP | 1.67% | 2025-12-31 |
| Renaissance Technologies LLC | 1.66% | 2025-12-31 |
| Paradigm Capital Management, Inc. | 1.65% | 2025-12-31 |

## 業務構成

| 業務線 | 營收 | 佔比 |
|---------|---------|-------|
| 生物技術 (初創公司) | 418630000 | 100% |

```vega-lite
{
  "$schema": "https://vega.github.io/schema/vega-lite/v5.json",
  "title": "MiMedx Group, Inc. Business Breakdown",
  "data": {
    "values": [
      {
        "segment": "生物技術 (初創公司)",
        "ratio": 100
      }
    ]
  },
  "mark": "arc",
  "encoding": {
    "theta": {
      "field": "ratio",
      "type": "quantitative"
    },
    "color": {
      "field": "segment",
      "type": "nominal"
    }
  }
}
```

## 地區分佈

| 地區 | 營收 | 佔比 |
|--------|---------|-------|
| 美國 | 418630000 | 100% |


---

> **免責聲明: 本文僅供參考，不構成任何投資建議。**